FDA Alerts
FDA Approves New HIV Drug
On March 25, 2011, FDA approved VIRAMUNE XR ( nevirapine ), a 400 mg extended release tablet formulation.
VIRAMUNE XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
Abacavir Update: Yes It's Still Safe, For Now
The FDA updated the public about an ongoing safety review of abacavir and a possible increased risk of heart attack. Since the announcement there has been conflicting information on the potential increased risk of heart attack.